Toll Free: 1-888-928-9744

Osteoarthritis Pain Global Clinical Trials Review, H1, 2016

Published: Mar 16, 2016 | Pages: 264 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Osteoarthritis Pain Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Osteoarthritis Pain Global Clinical Trials Review, H1, 2016" provides an overview of Osteoarthritis Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Osteoarthritis Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Osteoarthritis Pain to Central Nervous System Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Osteoarthritis Pain to Central Nervous System Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Osteoarthritis Pain Therapeutics Clinical Trials 28 Prominent Drugs 30 Latest Clinical Trials News on Osteoarthritis Pain 31 Mar 07, 2016: Nuvo Pharmaceuticals Announces Results from European Ankle Sprain Study with Pennsaid 2% 31 Feb 16, 2016: Flexion Therapeutics Reports Primary Endpoint Met in Pivotal Phase 3 Trial of Zilretta in Knee Osteoarthritis 32 Feb 01, 2016: Carbylan Therapeutics Reports Top-Line Results From COR1.1 Clinical Trial of Hydros-TA in Patients With OA of the Knee 33 Dec 17, 2015: Kitov Pharmaceuticals Reports Additional Data from its Phase III Trial on the Beneficial Blood Pressure Effects of KIT-302 33 Dec 15, 2015: Kitov Pharmaceuticals' Pivotal Phase III Trial Successfully Meets Primary Efficacy Endpoint 34 Clinical Trial Profile Snapshots 35 Appendix 261 Abbreviations 261 Definitions 261 Research Methodology 262 Secondary Research 262 About GlobalData 263 Contact Us 263 Disclaimer 263 Source 264
List of Tables
Osteoarthritis Pain Therapeutics, Global, Clinical Trials by Region, 2016* 6 Osteoarthritis Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Osteoarthritis Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Osteoarthritis Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10 Osteoarthritis Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11 Osteoarthritis Pain Therapeutics Clinical Trials, North America, Top Countries, 2016* 12 Osteoarthritis Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 13 Osteoarthritis Pain Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14 Proportion of Osteoarthritis Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 15 Osteoarthritis Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Osteoarthritis Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Osteoarthritis Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 18 Osteoarthritis Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Osteoarthritis Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Osteoarthritis Pain Therapeutics, Global, Clinical Trials by Phase, 2016* 21 Osteoarthritis Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22 Osteoarthritis Pain Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Osteoarthritis Pain Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Osteoarthritis Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Osteoarthritis Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26 Osteoarthritis Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Osteoarthritis Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29 Osteoarthritis Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30


List of Figures
Osteoarthritis Pain Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Osteoarthritis Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Osteoarthritis Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Osteoarthritis Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10 Osteoarthritis Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11 Osteoarthritis Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12 Osteoarthritis Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 13 Osteoarthritis Pain Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 14 Proportion of Osteoarthritis Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 15 Osteoarthritis Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Osteoarthritis Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Osteoarthritis Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 18 Osteoarthritis Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Osteoarthritis Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Osteoarthritis Pain Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21 Osteoarthritis Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22 Osteoarthritis Pain Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Osteoarthritis Pain Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Osteoarthritis Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Osteoarthritis Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26 Osteoarthritis Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Osteoarthritis Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28 Osteoarthritis Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30 GlobalData Methodology 262

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global activated carbon market size is likely to be valued at USD 5.3 billion by 2020; as per a new research report by Radiant Insights, Inc. Increase in commercial & residential waste water treatment demand owing to escalation in water prices is ant

Read More...

Global automotive relay market is anticipated to reach USD 12 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising need for high-frequency signals in automotive industry is expected to drive demand. These relays enhance driv

Read More...

Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanom

Read More...

Europe industrial air filtration market size is projected to reach USD 1,690.8 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing implementation in various industries such as metal, cement and food & beverages among ot

Read More...

Global intelligent transportation system (ITS) market is estimated to attain USD 38.68 billion by 2020, as per a new research report by Radiant Insights, Inc. Cost effectiveness along with escalating need for road safety is likely to boost global dem

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: sales@radiantinsights.com

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify